Funding
Series A · Healthtech

Atlas Oncology Partners raises $28M Series A

Atlas Oncology Partners raised $28 million in Series A financing announced in February.

Updated Oct 16, 2026By RoundOS Funding desk

Flare Capital Partners and Rubicon Founders are among its investors. The company focuses on cancer care during and beyond treatment.

Funding history

Series A · This round$28M

Sources

  1. Atlas Oncology Partnersprojectstartups.com
  2. businesswire.com

Similar rounds

All Healthtech rounds →
Guoke Brain-Computer

Beijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.

UndisclosedSeed · Oct 23, 2026
Star Therapeutics

Biotechnology company discovering and developing antibody therapies for diseases with significant unmet need.

$200MPrivate financing · Oct 23, 2026
Pathos AI

Clinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.

$237MSeries E · Oct 23, 2026
Knowledge Work

Tokyo software company developing sales AI agents, an agent operating platform and consulting services for enterprise sales teams.

¥4.8BSeries C debt second close · Oct 23, 2026

Related